Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Ther ; 22(1): 59-68, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23982166

ABSTRACT

Lentiviral vectors are widely used in basic research and clinical applications for gene transfer and long-term expression; however, safety issues have not yet been completely resolved. In this study, we characterized hepatocarcinomas that developed in mice 1 year after in utero administration of a feline-derived lentiviral vector. Mapped viral integration sites differed among tumors and did not coincide with the regions of chromosomal aberrations. Furthermore, gene expression profiling revealed that no known cancer-associated genes were deregulated in the vicinity of viral integrations. Nevertheless, five of the six tumors exhibited highly significant upregulation of E2F target genes, of which a majority are associated with oncogenesis, DNA damage response, and chromosomal instability. We further show in vivo and in vitro that E2F activation occurs early on following transduction of both fetal mice and cultured human hepatocytes. On the basis of the similarities in E2F target gene expression patterns among tumors and the lack of evidence implicating insertional mutagenesis, we propose that transduction of fetal mice with a feline lentiviral vector induces E2F-mediated major cellular processes that drive hepatocytes toward uncontrolled proliferation culminating in tumorigenesis.


Subject(s)
E2F Transcription Factors/metabolism , Fetus , Genetic Vectors/genetics , Lentiviruses, Feline/genetics , Liver Neoplasms/etiology , Transduction, Genetic , Animals , Cats , Cell Transformation, Neoplastic/genetics , Chromosome Aberrations , DNA Damage , Gene Dosage , Gene Expression , Gene Expression Regulation , Humans , Liver Neoplasms/metabolism , Mice , Mutagenesis, Insertional , Transcriptome , Transgenes , Virus Integration
2.
Vet Immunol Immunopathol ; 143(3-4): 235-42, 2011 Oct 15.
Article in English | MEDLINE | ID: mdl-21813188

ABSTRACT

Gene therapy approaches to the treatment of HIV infection have targeted both viral gene expression and the cellular factors that are essential for virus replication. However, significant concerns have been raised regarding the potential toxic effects of such therapies, the emergence of resistant viral variants and unforeseen biological consequences such as enhanced susceptibility to unrelated pathogens. Novel restriction factors formed by the fusion of the tripartite motif protein (TRIM5) and cyclophilin A (CypA), or "TRIMCyps", offer an effective antiviral defence strategy with a very low potential for toxicity. In order to investigate the potential therapeutic utility of TRIMCyps in gene therapy for AIDS, a synthetic fusion protein between feline TRIM5 and feline CypA was generated and transduced into cells susceptible to infection with feline immunodeficiency virus (FIV). The synthetic feline TRIMCyp was highly efficient at preventing infection with both HIV and FIV and the cells resisted productive infection with FIV from either the domestic cat or the puma. Feline TRIMCyp and FIV infection of the cat offers a unique opportunity to evaluate TRIMCyp-based approaches to genetic therapy for HIV infection and the treatment of AIDS.


Subject(s)
Artificial Gene Fusion , Carrier Proteins/genetics , Cyclophilin A/genetics , Lentiviruses, Feline/genetics , Recombinant Fusion Proteins/metabolism , Acquired Immunodeficiency Syndrome/therapy , Animals , Antiviral Restriction Factors , Cats/virology , Genetic Therapy , Humans , Immunodeficiency Virus, Feline/genetics , Recombinant Fusion Proteins/genetics , Tripartite Motif Proteins , Ubiquitin-Protein Ligases
3.
Virology ; 342(1): 60-76, 2005 Nov 10.
Article in English | MEDLINE | ID: mdl-16120451

ABSTRACT

Feline immunodeficiency virus (FIV) causes fatal disease in domestic cats via T cell depletion-mediated immunodeficiency. Pumas and lions are hosts for apparently apathogenic lentiviruses (PLV, LLV) distinct from FIV. We compared receptor use among these viruses by: (1) evaluating target cell susceptibility; (2) measuring viral replication following exposure to specific and non-specific receptor antagonists; and (3) comparing Env sequence and structural motifs. Most isolates of LLV and PLV productively infected domestic feline T cells, but differed from domestic cat FIV by infecting cells independent of CXCR4, demonstrating equivalent or enhanced replication following heparin exposure, and demonstrating substantial divergence in amino acid sequence and secondary structure in Env receptor binding domains. PLV infection was, however, inhibited by CD134/OX40 antibody. Thus, although PLV and LLV infection interfere with FIV superinfection, we conclude that LLV and PLV utilize novel, more promiscuous mechanisms for cell entry than FIV, underlying divergent tropism and biological properties of these viruses.


Subject(s)
Lentiviruses, Feline/pathogenicity , Amino Acid Sequence , Animals , Base Sequence , Cats , Cell Line , DNA, Viral/genetics , Glycosylation , Immunodeficiency Virus, Feline/genetics , Immunodeficiency Virus, Feline/immunology , Immunodeficiency Virus, Feline/pathogenicity , Immunodeficiency Virus, Feline/physiology , Lentiviruses, Feline/genetics , Lentiviruses, Feline/immunology , Lentiviruses, Feline/physiology , Lions , Molecular Sequence Data , Puma , Receptors, CXCR4/antagonists & inhibitors , Receptors, CXCR4/physiology , Receptors, OX40 , Receptors, Tumor Necrosis Factor/antagonists & inhibitors , Receptors, Virus/antagonists & inhibitors , Receptors, Virus/physiology , Sequence Homology, Amino Acid , T-Lymphocytes/immunology , T-Lymphocytes/virology , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics , Viral Envelope Proteins/physiology , Virulence , Virus Replication
4.
Biochem Biophys Res Commun ; 320(3): 998-1006, 2004 Jul 30.
Article in English | MEDLINE | ID: mdl-15240147

ABSTRACT

Liver-directed gene therapy has the potential for treatment of numerous inherited diseases affecting metabolic functions. The aim of this study was to evaluate gene expression in hepatocytes using feline immunodeficiency virus-based lentiviral vectors, which may be potentially safer than those based on human immunodeficiency virus. In vitro studies revealed that gene expression was stable for up to 24 days post-transduction and integration into the host cell genome was suggested by Alu PCR and Southern blot analyses. Systemic in vivo administration of viral particles by the hydrodynamics method resulted in high levels of gene expression exclusively in the liver for over 7 months whereas injection of plasmid DNA by the same method led to transient expression levels. Our studies suggest that feline immunodeficiency-based lentiviral vectors specifically transduce liver cells and may be used as a novel vehicle of gene delivery for treatment of metabolic disease.


Subject(s)
Carcinoma, Hepatocellular/genetics , Gene Expression Regulation, Neoplastic/genetics , Immunodeficiency Virus, Feline/genetics , Transfection/methods , Animals , Cats , Cell Line, Tumor , Feline Acquired Immunodeficiency Syndrome/genetics , Feline Acquired Immunodeficiency Syndrome/virology , Genetic Therapy/methods , Genetic Vectors/genetics , Humans , Lentiviruses, Feline/genetics , Primates , Transgenes/genetics
5.
J Virol ; 75(11): 5129-40, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11333894

ABSTRACT

Development of safe and effective gene transfer systems is critical to the success of gene therapy protocols for human diseases. Currently, several primate lentivirus-based gene transfer systems, such as those based on human and simian immunodeficiency viruses (HIV/SIV), are being tested; however, their use in humans raises safety concerns, such as the generation of replication-competent viruses through recombination with related endogenous retroviruses or retrovirus-like elements. Due to the greater phylogenetic distance from primate lentiviruses, feline immunodeficiency virus (FIV) is becoming the lentivirus of choice for human gene transfer systems. However, the safety of FIV-based vector systems has not been tested experimentally. Since lentiviruses such as HIV-1 and SIV have been shown to cross-package their RNA genomes, we tested the ability of FIV RNA to get cross-packaged into primate lentivirus particles such as HIV-1 and SIV, as well as a nonlentiviral retrovirus such as Mason-Pfizer monkey virus (MPMV), and vice versa. Our results reveal that FIV RNA can be cross-packaged by primate lentivirus particles such as HIV-1 and SIV and vice versa; however, a nonlentivirus particle such as MPMV is unable to package FIV RNA. Interestingly, FIV particles can package MPMV RNA but cannot propagate the vector RNA further for other steps of the retrovirus life cycle. These findings reveal that diverse retroviruses are functionally more similar than originally thought and suggest that upon coinfection of the same host, cross- or copackaging may allow distinct retroviruses to generate chimeric variants with unknown pathogenic potential.


Subject(s)
Genetic Vectors , Lentiviruses, Feline/genetics , Lentiviruses, Primate/genetics , RNA, Viral , Animals , COS Cells , Capsid/metabolism , Gene Transfer Techniques , HIV-1/genetics , HIV-1/growth & development , Humans , Lentiviruses, Feline/growth & development , Lentiviruses, Primate/growth & development , Mason-Pfizer monkey virus/genetics , Mason-Pfizer monkey virus/growth & development , Sequence Homology , Simian Immunodeficiency Virus/genetics , Simian Immunodeficiency Virus/growth & development , Species Specificity , Transformation, Genetic
6.
Semin Vet Med Surg Small Anim ; 10(4): 251-5, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8820600

ABSTRACT

Human immunodeficiency virus and feline immunodeficiency virus are both lentiviruses that cause immunosuppressive disease. Similarities between these diseases have promoted the study of feline immunodeficiency virus as a model for human immunodeficiency virus. Not only have lentiviruses been found in domestic cats but they have been found in nondomestic felids as well. Florida panthers, African lions, and other nondomestic felids have been found to have antibodies directed against lentiviruses and each nondomestic cat has antibodies to a virus that is specific for that species. The phylogenetic relationships of these lentiviruses have been studied and mapped using nucleic acid sequencing technology. Phylogenetic mapping has been an important step for future development of vaccines and antiviral therapy.


Subject(s)
Carnivora , Lentivirus Infections/veterinary , Lentiviruses, Feline , Animals , Antibodies, Viral/blood , Cats , Female , Lentivirus Infections/epidemiology , Lentivirus Infections/immunology , Lentivirus Infections/virology , Lentiviruses, Feline/genetics , Lentiviruses, Feline/immunology , Male , Phylogeny
SELECTION OF CITATIONS
SEARCH DETAIL
...